M
Mohammed Nejjari
Researcher at University of Paris
Publications - 26
Citations - 2346
Mohammed Nejjari is an academic researcher from University of Paris. The author has contributed to research in topics: Mitral valve & Mitral regurgitation. The author has an hindex of 12, co-authored 22 publications receiving 1640 citations. Previous affiliations of Mohammed Nejjari include Claude Bernard University Lyon 1.
Papers
More filters
Journal ArticleDOI
Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation
Jean-François Obadia,David Messika-Zeitoun,Guillaume Leurent,Bernard Iung,Guillaume Bonnet,Nicolas Piriou,Thierry Lefèvre,Christophe Piot,Frédéric Rouleau,Didier Carrié,Mohammed Nejjari,Patrick Ohlmann,Florence Leclercq,Christophe Saint Etienne,Emmanuel Teiger,Lionel Leroux,Nicole Karam,Nicolas Michel,Martine Gilard,Erwan Donal,Jean-Noël Trochu,B. Cormier,Xavier Armoiry,Florent Boutitie,Delphine Maucort-Boulch,Cécile Barnel,Géraldine Samson,Patrice Guerin,Alec Vahanian,Nathan Mewton +29 more
TL;DR: Among patients with severe secondary mitral regurgitation, the rate of death or unplanned hospitalization for heart failure at 1 year did not differ significantly between patients who underwent percutaneous mitral‐valve repair in addition to receiving medical therapy and those who received medical therapy alone.
Journal ArticleDOI
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification
Mayra Guerrero,Marina Urena,Dominique Himbert,Dee Dee Wang,Mackram F. Eleid,Susheel Kodali,Isaac George,Tarun Chakravarty,Moses Mathur,David Holzhey,Ashish Pershad,H. Kenith Fang,Daniel O'Hair,Noah Jones,Vaikom S. Mahadevan,Nicolas Dumonteil,Josep Rodés-Cabau,Nicolo Piazza,Enrico Ferrari,Daniel Ciaburri,Mohammed Nejjari,Augustin Delago,Paul Sorajja,Firas Zahr,Vivek Rajagopal,Brian Whisenant,Pinak B. Shah,Jan-Malte Sinning,Adam Witkowski,Hélène Eltchaninoff,Danny Dvir,Bena Martin,Guilherme F. Attizzani,Diego Felipe Gaia,Nagela S. V. Nunes,Amir-Ali Fassa,Faraz Kerendi,Gregory Pavlides,Vijay Iyer,Georges Kaddissi,Christian Witzke,James Wudel,Gregory J. Mishkel,Bryan Raybuck,Chi Wang,Ron Waksman,Igor F. Palacios,Alain Cribier,John G. Webb,Vinnie Bapat,Mark Reisman,Raj Makkar,Martin B. Leon,Charanjit S. Rihal,Alec Vahanian,William W. O'Neill,Ted Feldman +56 more
TL;DR: The TMVR in MAC Global Registry as mentioned in this paper is a multicenter registry that collects data on outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification.
Journal ArticleDOI
Early Outcomes of Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification
Mackram F. Eleid,Brian Whisenant,Allison K. Cabalka,Mathew R. Williams,Mohammed Nejjari,David Attias,Neil Fam,Nicholas Amoroso,Thomas A. Foley,Peter M. Pollak,Oluseun Alli,Sorin V. Pislaru,Sameh M. Said,Joseph A. Dearani,Charanjit S. Rihal +14 more
TL;DR: Transfemoral percutaneous transvenous mitral valve implantation in high-risk patients with degenerated bioprosthesis is safe, effective, and associated with rapid improvement in hemodynamics, short length of stays, and improved functional status.
Journal ArticleDOI
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.
Bernard Iung,Xavier Armoiry,Alec Vahanian,Florent Boutitie,Nathan Mewton,Jean-Noël Trochu,Thierry Lefèvre,David Messika-Zeitoun,David Messika-Zeitoun,Patrice Guerin,Bertrand Cormier,Eric Brochet,Hélène Thibault,Dominique Himbert,Sophie Thivolet,Guillaume Leurent,Guillaume Bonnet,Erwan Donal,Nicolas Piriou,Christophe Piot,Gilbert Habib,Frédéric Rouleau,Didier Carrié,Mohammed Nejjari,Patrick Ohlmann,Christophe Saint Etienne,Lionel Leroux,Martine Gilard,Géraldine Samson,Gilles Rioufol,Delphine Maucort-Boulch,Jean-François Obadia,Mitra-Fr Investigators +32 more
TL;DR: The MITRA‐FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for heart failure at 12 months compared with guideline‐directed medical treatment alone.
Journal ArticleDOI
Transfemoral Implantation of Transcatheter Heart Valves After Deterioration of Mitral Bioprosthesis or Previous Ring Annuloplasty
Claire Bouleti,Amir-Ali Fassa,Dominique Himbert,Eric Brochet,Gregory Ducrocq,Mohammed Nejjari,Walid Ghodbane,Jean-Pol Depoix,Patrick Nataf,Alec Vahanian +9 more
TL;DR: This single-center series suggests that transfemoral THV implantation for deterioration of mitral bioprosthesis or surgical repair is feasible in selected patients and improves early hemodynamic and midterm functional status.